Practical synthesis of L/T calcium channel blocker ACT-280778

摘要

Chiral bicyclic benzimidazole ACT-280778 is a L/T calcium channel blocker potentially indicated for the treatment of hypertension and angina pectoris. There was a need at Actelion for a robust, safe and scalable production of the active pharmaceutical ingredient to supply material for preclinical and clinical studies.